JNJ-61803534 |
| Katalog-Nr.GC69318 |
JNJ-61803534 ist ein wirksamer, oral aktiver RORγt-Inhibitor mit einer IC50 von 9,6 nM. JNJ-61803534 hat entzündungshemmende Aktivität. Unter Th17-Differenzierungsbedingungen hemmt JNJ-61803534 die Produktion von IL-17A durch menschliche CD4+ T-Zellen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1917306-14-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for JNJ-61803534
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for JNJ-61803534
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *